CREB1 and neoplasm: Since CREB has many oncogenic properties and participates in the induction of resistance mechanisms, it is a promising target for the treatment of many tumor types; nevertheless, for tumor types in which high levels of CREB expression are associated with better outcomes, this approach may not be suitable.